Streamlining Telehealth for Expanded PrEP Utilization Through Community Partnerships
STEP-UP
1 other identifier
interventional
92
1 country
1
Brief Summary
The goal of this study is to learn if STEP-UP (Streamlining Telehealth for Expanded PrEP Utilization through community Partnerships) works to expand access to PrEP for people who could benefit from HIV prevention tools. STEP-UP is an innovative model for PrEP delivery that positions community-based organizations (CBOs) as hubs for PrEP access. STEP-UP builds on the established trust, community expertise, and comprehensive services of CBOs serving individuals who could benefit from HIV prevention tools, integrating telehealth PrEP delivery into their existing infrastructure through partnership with a local telehealth PrEP program. By enabling CBOs to offer telePrEP navigation within their array of health and social services, STEP-UP creates accessible, comprehensive care centers that address barriers to PrEP access faced by individuals who could benefit from HIV prevention tools. The main questions it aims to answer are:
- 1.Is STEP-UP acceptable and feasible to implement in community settings?
- 2.Does STEP-UP increase PrEP prescription rates compared to the existing direct-to-consumer telehealth model?
- 3.Complete surveys about their experiences with the program
- 4.Participate in an interview to share their perspectives and feedback about the program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2025
CompletedFirst Posted
Study publicly available on registry
November 24, 2025
CompletedStudy Start
First participant enrolled
March 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
April 13, 2026
March 1, 2026
2.2 years
November 17, 2025
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PrEP Prescription Rate
The proportion of clients who receive a PrEP prescription among those who schedule a telehealth appointment with a PrEP provider. This measure will be compared between clients referred through the STEP-UP partner site model and those engaged through the existing direct-to-client telehealth model.
18-month pilot period
Secondary Outcomes (2)
Acceptability of STEP-UP
Immediately after initial engagement with Community TelePrEP Navigator and 2-4 weeks after initial engagement
Usability of STEP-UP
Immediately after initial engagement with Community TelePrEP Navigator and 2-4 weeks after initial engagement
Study Arms (2)
STEP-UP Partner Site Model
EXPERIMENTALSTEP-UP is a partner site model that aims to expand access to telehealth PrEP services for people who could benefit from HIV prevention tools. The first year of the proposed project is dedicated to collaboratively developing and refining the specifics of the STEP-UP model. While the final model will be determined by this formative process, key components will likely include: 1) Establishing a private, on-site space at community-based organizations (CBOs) where clients can engage in telehealth visits with remote PrEP providers; 2) Providing CBOs with the necessary technology and equipment to facilitate telehealth visits; 3) Training CBO staff as Community TelePrEP Navigators to help clients prepare for and follow-up after telehealth appointments, and conduct community-based PrEP education and linkage. Clients referred through the STEP-UP model can schedule appointments with assistance from a Community TelePrEP Navigator or through documented referrals to the self-scheduling tool on the
Direct-to-Consumer Telehealth Model
ACTIVE COMPARATORThe existing direct-to-consumer model for telehealth PrEP delivery through the Philadelphia TelePrEP Program. In this model, appointments can be scheduled with assistance from patient navigators and chat operators, or through the self-scheduling tool on the website. This represents the current standard approach for telehealth PrEP service delivery and serves as the comparison group for assessing the preliminary effectiveness of the STEP-UP model.
Interventions
The existing direct-to-consumer model for telehealth PrEP delivery through the Philadelphia TelePrEP Program. In this model, appointments can be scheduled with assistance from patient navigators and chat operators, or through the self-scheduling tool on the website. This represents the current standard approach for telehealth PrEP service delivery and serves as the comparison group for assessing the preliminary effectiveness of the STEP-UP model.
STEP-UP is a partner site model that aims to expand access to telehealth PrEP services for people who could benefit from HIV prevention tools. The first year of the proposed project is dedicated to collaboratively developing and refining the specifics of the STEP-UP model. While the final model will be determined by this formative process, key components will likely include: 1) Establishing a private, on-site space at community-based organizations (CBOs) where clients can engage in telehealth visits with remote PrEP providers; 2) Providing CBOs with the necessary technology and equipment to facilitate telehealth visits; 3) Training CBO staff as Community TelePrEP Navigators to help clients prepare for and follow-up after telehealth appointments, and conduct community-based PrEP education and linkage. Clients referred through the STEP-UP model can schedule appointments with assistance from a Community TelePrEP Navigator or through documented referrals to the self-scheduling tool on the
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- National Institute of Mental Health (NIMH)collaborator
- University of Pennsylvanialead
- Thomas Jefferson Universitycollaborator
Study Sites (1)
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 17, 2025
First Posted
November 24, 2025
Study Start
March 26, 2026
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
April 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- The investigators will submit our data to the NDA as soon as possible after study completion and data cleaning, and no later than upon publication of the primary study findings. The investigators will protect the rights and privacy of human subjects who participate in sponsored research by redacting all identifiers, and adopting other strategies to minimize risks of unauthorized disclosure of personal identifiers. The NDA will determine the duration of data preservation. To date, the NDA has not removed any data that has been deposited in the repository.
- Access Criteria
- Researchers interested in accessing the data will follow the NDA standard access procedures. The NDA Data Access Committee will review all requests and determine which ones to approve. If granted access, researchers will have permission to use the data for one year, with the option to renew their access request.
De-identified individual participant data generated by this study will be archived in the National Institute of Mental Health Data Archive (NDA). The NDA is a secure, federated data repository that provides infrastructure for sharing research data, tools, methods, and analyses enabling collaborative science and discovery. All direct identifiers will be removed and indirect identifiers will be generalized to prevent re-identification.